FDA Approves At-Home Test for Breast Cancer The biotech company 23andMe was given the green light to send customers the test , which gives them a report about three BRCA1/BRA2 gene mutations. The CDC says the BRCA mutations tend to be present in about 2 percent of Ashkenazi Jewish ...
News
- Copy of: FDA Approves At-Home Test for Breast Cancer
- CellRight Technologies Signs Multi-Year Distribution Agreement With Arthrex, Inc.
SAN ANTONIO–(BUSINESS WIRE)–Tissue Regenix Group (AIM:TRX) (“Tissue Regenix” or “The Group”) the regenerative medical devices ... In August 2017 Tissue Regenix acquired CellRight Technologies®, a biotech company that specializes in regenerative medicine and is dedicated to the…
- Fate Therapeutics reports 4Q loss
The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 24 cents per share. The clinical-stage biotech company that develops stem cell treatments posted revenue of $1 million in the period, meeting Street…
- Can the Bernie Sanders 'Our Revolution' Put Progressive Populism Back Into the Texas ...
... Rick Trevino for the 23rd Congressional District that stretches from San Antonio west to El Paso; Derrick Crowe in the crowded field for the 21st Congressional District that goes from San Antonio to Austin; and Northern style kung fu practitioner and biomedical PhD…
- Local LGBT Candidates Look Toward Primary Election
He received a Masters of Science from the University of Texas at San Antonio and was an adjunct faculty member at San Antonio College for seven years. His career includes stints at Southwest Analytical Concepts, Southwest Foundation for Biomedical Research, and the Texas Commission on Alcohol…